Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
RUSSELL, Stuart D, BLACKWELL, Kimberly L, LAWRENCE, Julia, PIPPEN, John E, ROE, Matthew T, WOOD, Freda, PATON, Virginia, HOLMGREN, Eric, MAHAFFEY, Kenneth W
Published in Journal of clinical oncology (20.07.2010)
Published in Journal of clinical oncology (20.07.2010)
Get full text
Journal Article
Phase II, Randomized, Double-Blind Study of Two Dose Levels of Arzoxifene in Patients With Locally Advanced or Metastatic Breast Cancer
BUZDAR, Aman, O'SHAUGHNESSY, Joyce A, BOOSER, Daniel J, PIPPEN, John E, JONES, Stephen E, MUNSTER, Pamela N, PETERSON, Patrick, MELEMED, Allen S, WINER, Eric, HUDIS, Clifford
Published in Journal of clinical oncology (15.03.2003)
Published in Journal of clinical oncology (15.03.2003)
Get full text
Journal Article
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study
Gong, Yun, Dr, Yan, Kai, MS, Lin, Feng, MD, Anderson, Keith, MS, Sotiriou, Christos, MD, Andre, Fabrice, MD, Holmes, Frankie A, MD, Valero, Vicente, Prof, Booser, Daniel, Prof, Pippen, John E, MD, Vukelja, Svetislava, MD, Gomez, Henry, MD, Mejia, Jaime, MD, Barajas, Luis J, MD, Hess, Kenneth R, PhD, Sneige, Nour, Prof, Hortobagyi, Gabriel N, Prof, Pusztai, Lajos, MD, Symmans, W Fraser, MD
Published in The lancet oncology (01.03.2007)
Published in The lancet oncology (01.03.2007)
Get full text
Journal Article
Carcinoma en cuirasse
Culver, Ashlee L, Metter, David M, Pippen, Jr, John E
Published in Proceedings - Baylor University. Medical Center (03.04.2019)
Published in Proceedings - Baylor University. Medical Center (03.04.2019)
Get full text
Journal Article
Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
Holmes, Frankie Ann, Hellerstedt, Beth A., Pippen, John E., Vukelja, Svetislava J., Collea, Rufus P., Kocs, Darren M., Blum, Joanne L., McIntyre, Kristi J., Barve, Minal A., Brooks, Barry D., Osborne, Cynthia R., Wang, Yunfei, Asmar, Lina, O'Shaughnessy, Joyce
Published in Cancer medicine (Malden, MA) (01.06.2018)
Published in Cancer medicine (Malden, MA) (01.06.2018)
Get full text
Journal Article